KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Raw Materials (2016 - 2025)

Boston Scientific (BSX) has disclosed Raw Materials for 17 consecutive years, with $849.0 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 3.66% to $849.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $849.0 million through Dec 2025, up 3.66% year-over-year, with the annual reading at $849.0 million for FY2025, 3.66% up from the prior year.
  • Raw Materials hit $849.0 million in Q4 2025 for Boston Scientific, roughly flat from $849.0 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $860.0 million in Q3 2024 to a low of $366.0 million in Q1 2021.
  • Historically, Raw Materials has averaged $666.8 million across 5 years, with a median of $727.5 million in 2023.
  • Biggest five-year swings in Raw Materials: dropped 21.99% in 2021 and later surged 41.09% in 2023.
  • Year by year, Raw Materials stood at $452.0 million in 2021, then rose by 21.24% to $548.0 million in 2022, then soared by 41.06% to $773.0 million in 2023, then increased by 5.95% to $819.0 million in 2024, then rose by 3.66% to $849.0 million in 2025.
  • Business Quant data shows Raw Materials for BSX at $849.0 million in Q4 2025, $849.0 million in Q3 2025, and $835.0 million in Q2 2025.